Anti-tumor activity of PM01183 (lurbinectedin) in BRCA1/2-associated metastatic breast cancer patients: results of a single-agent phase II trial
Balmaña, J., Cruz, C., Arun, B.K., Telli, M., Garber, J., Domchek, S., Fernandez, C.M., Kahatt, C., Szyldergemajn, S., Soto-Matos, A., Haza, A. Perezdela, Fidalgo, J.A. Perez, Lluch-Hernandez, A., Antolin, S., Tung, N.M., Vahdat, L.T., Lopez, R., Isakoff, S.J.J.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article